NCT03217422: An ongoing trial by Novartis Pharmaceuticals
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03217422 |
|---|---|
| Title | A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of VAY736 in Autoimmune Hepatitis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 15, 2018 |
| Completion date | Dec. 28, 2023 |
| Required reporting date | Dec. 28, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |